| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Wang,Shu-Wen | Chairman | 0.01% | |
| Hong,Rui-Ting | Director | 1.54% | |
| BEI YU LTD. | Director | 0.00% | |
| XIN XIN Ltd. | Director | 0.00% | |
| Chen,Kun-Tang | Director | 0.16% | |
| Su,Bai-Huang | Director | 0.00% | |
| Xie,Guo-Song | Director | 9.40% | YI YUAN INVESTMENT CO., LTD. |
| Qu,Jian-Zhong | Director | 0.00% | |
| You,Zheng-Ping | Independent Director | 0.00% | |
| Liu,Nai-Ming | Independent Director | 0.00% | |
| Shi,Tian-Wei | Independent Director | 0.00% | |
| Chen,Xiao-Kai | Independent Director | 0.00% | |
| Lai,Qiu-Jun | Independent Director | 0.00% |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Operating income | 36,828,499 | 30,790,462 | 39,736,173 |
| Operating cost | 25,459,513 | 21,111,381 | 28,670,846 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 11,368,986 | 9,679,081 | 11,065,327 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 11,368,986 | 9,679,081 | 11,065,327 |
| Operating expenses | 3,613,561 | 3,130,231 | 3,328,319 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | 7,755,425 | 6,548,850 | 7,737,008 |
| Non-operating income and expenses | 595,503 | 126,748 | 803,393 |
| Net profit (loss) before tax | 8,350,928 | 6,675,598 | 8,540,401 |
| Income tax expense (benefits) | 1,710,076 | 1,499,131 | 1,750,053 |
| Net profit (loss) of ongoing business for the current period | 6,640,852 | 5,176,467 | 6,790,348 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | 6,640,852 | 5,176,467 | 6,790,348 |
| Other comprehensive profit (loss), net | 313,928 | 16,388 | 494,594 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | 6,954,780 | 5,192,855 | 7,284,942 |
| Net profit (loss) attributable to owners of parent company | 6,640,852 | 5,176,467 | 6,790,348 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | - | - | - |
| Comprehensive profit (loss) attributable to owners of parent company | 6,954,780 | 5,192,855 | 7,284,942 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | - | - | - |
| Basic earnings per share (yuan) | 24 | 18 | 24 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | 4,720,354 | 4,664,144 | 12,318,001 |
| Net cash inflows (outflows) from investing activities | -791,797 | -1,835,895 | -4,806,608 |
| Net cash inflow (outflow) from financing activities | -3,109,407 | -6,051,743 | -3,253,831 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | -14,704 | 14,956 | 4,862 |
| Increase (decrease) in cash and cash equivalents in the current period | 804,446 | -3,208,538 | 4,262,424 |
| Beginning balance of cash and cash equivalents | 2,813,733 | 6,022,271 | 1,759,847 |
| Ending balance of cash and cash equivalents | 3,618,179 | 2,813,733 | 6,022,271 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current asset | 21,508,022 | 17,398,018 | 18,355,052 |
| Non-current asset | 14,357,098 | 14,434,717 | 15,008,471 |
| Total asset | 35,865,120 | 31,832,735 | 33,363,523 |
| Current liability | 6,766,856 | 6,080,958 | 7,577,232 |
| Non-current liability | 176,603 | 81,196 | 644,324 |
| Total liability | 6,943,459 | 6,162,154 | 8,221,556 |
| share capital | 2,743,671 | 2,743,671 | 2,743,671 |
| Equity - secruity token | - | - | - |
| capital reserve | 3,769,803 | 3,769,547 | 3,769,547 |
| retained earning | 22,080,917 | 19,117,834 | 18,604,885 |
| Other equity | 327,270 | 39,529 | 23,864 |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | 28,921,661 | 25,670,581 | 25,141,967 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | - | - | - |
| Total Equity | 28,921,661 | 25,670,581 | 25,141,967 |
| Share capital awaiting retirement (unit: share) | - | - | - |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 105 | 93 | 91 |
| 標案名稱 | 機關名稱 | 決標日期 | 決標金額 | 是否得標 |
|---|---|---|---|---|
| 109年隔離衣緊急採購案 | 衛生福利部疾病管制署 | 109/03/06 | 12540000.0 | 是 |
| 日期 | 違反法規法條 | 罰鍰金額 |
|---|---|---|
| 2024/05/07 | Paragraph 1, Article 6 of the Occupational Safety and Health Act; Paragraph 1, Article 6 of the Occupational Safety and Health Act; Paragraph 1, Article 6 of the Occupational Safety and Health Act | |
| 2020/11/09 | Paragraph 1, Article 6 of the Occupational Safety and Health Act | |
| 2018/09/10 | Article 24 of the Labor Standards Act | |
| 2017/10/25 | Paragraph 1, Article 6 of the Occupational Safety and Health Act |
